Contribution: Industrial Research Assistance Program – Contributions to Firms
EMAGIX INC.
$248,729.00
Development of AI-based Image Analysis Technology for the Early Diagnosis of Diabetes Retinopathy
FY 2021-22 · 2021-08-23
Summary
The goal of the project is to further the development the Firm's artificial intelligence capabilities and enhance the ability to provide useful analysis from multi-modal data sources in the diagnosis of retinal disorders.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Halifax|Halifax, Nova Scotia, Canada
Recipient Type
For-profit organization
Business Number
788528321
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2021-08-23 | 2021-22 | $178,688.00 |
| 2 | 2021-08-23 | 2021-22 | $196,880.00 |
| 4 | 2021-08-23 | 2021-22 | $236,040.00 |
| 5 | 2021-08-23 | 2021-22 | $248,729.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 21 days. The total amended value is 12,689 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 21 jours. La valeur totale des modifications est de 12 689 dollars.
Agreement End Date
2023-03-31
Agreement Number
977488
Agreement Start Date
2021-08-23
Agreement Title
Development of AI-based Image Analysis Technology for the Early Diagnosis of Diabetes Retinopathy
Agreement Title (French)
Développement d'une technologie d'analyse d'images basée sur l'IA pour le diagnostic précoce de la rétinopathie diabétique
Agreement Type
Contribution
Agreement Value
$248,729.00
Amendment Date
2023-03-03
Amendment Number
5
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The goal of the project is to further the development the Firm's artificial intelligence capabilities and enhance the ability to provide useful analysis from multi-modal data sources in the diagnosis of retinal disorders.
Description (French)
L'objectif du projet est de poursuivre le développement des capacités d'intelligence artificielle de l'entreprise et d'améliorer la capacité à fournir une analyse utile à partir de sources de données multimodales pour le diagnostic de troubles rétiniens.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Halifax
Federal Riding (French)
Halifax
Federal Riding Number
12005
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
788528321
Recipient City
Halifax|Halifax
Recipient Country
CA
Recipient Legal Name
EMAGIX INC.
Recipient Postal Code
B3H 0A8
Recipient Province or Territory
NS
Recipient Type
F
Reference Number
172-2021-2022-Q2-977488
